|
|
 |
|
| | |
| | | | | |
organism-gene
|
|
PR:P04275 |
von Willebrand factor (human)
|
hVWF
|
"A von Willebrand factor that is encoded in the genome of human." [PRO:DNx, UniProtKB:P04275]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-sequence
|
|
PR:P04275-1 |
von Willebrand factor isoform 1 (human)
|
hVWF/iso:1
|
"A von Willebrand factor isoform 1 that is encoded in the genome of human." [PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000043586 |
von Willebrand factor isoform 1 cleaved 1 (human)
|
hVWF/iso:1/Clv:1
|
"A von Willebrand factor isoform 1 (human) that is the N-terminal part after signal peptide removal and cleavage between residues Arg-763 and Ser-764. UniProtKB:P04275-1, 23-763." [PRO:DAN]
|
|
Yes |
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000043993 |
von Willebrand factor isoform 1 cleaved 2 (human)
|
hVWF/iso:1/Clv:2
|
"A von Willebrand factor isoform 1 (human) that is the C-terminal part after cleavage between residues Arg-763 and Ser-764. UniProtKB:P04275-1, 764-2813." [PRO:DAN]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-sequence
|
|
PR:P04275-2 |
von Willebrand factor isoform h2 (human)
|
hVWF/iso:h2
|
"A von Willebrand factor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P04275-2." [PRO:DNx, UniProtKB:P04275]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000028364 |
von Willebrand factor, signal peptide removed form (human)
|
hVWF/SigPep-
|
"A von Willebrand factor, signal peptide removed form in human. Example: UniProtKB:P04275-1, 23-763." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000043586 |
von Willebrand factor isoform 1 cleaved 1 (human)
|
hVWF/iso:1/Clv:1
|
"A von Willebrand factor isoform 1 (human) that is the N-terminal part after signal peptide removal and cleavage between residues Arg-763 and Ser-764. UniProtKB:P04275-1, 23-763." [PRO:DAN]
|
|
Yes |
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053341 |
von Willebrand factor N-glycosylated 1 (human)
|
hVWF/NGlyco:1
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-1515 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P04275-1, Asn-1515, MOD:00160~GNO:G08293MJ." [GlyGen:P04275-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053342 |
von Willebrand factor N-glycosylated 2 (human)
|
hVWF/NGlyco:2
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-1515 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G16175ZV. Example: UniProtKB:P04275-1, Asn-1515, MOD:00160~GNO:G16175ZV." [GlyGen:P04275-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053343 |
von Willebrand factor N-glycosylated 3 (human)
|
hVWF/NGlyco:3
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P04275-1, Asn-156, MOD:00160~GNO:G00912UN." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053344 |
von Willebrand factor N-glycosylated 4 (human)
|
hVWF/NGlyco:4
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G04784US. Example: UniProtKB:P04275-1, Asn-156, MOD:00160~GNO:G04784US." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053345 |
von Willebrand factor N-glycosylated 5 (human)
|
hVWF/NGlyco:5
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P04275-1, Asn-156, MOD:00160~GNO:G06247RL." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053346 |
von Willebrand factor N-glycosylated 6 (human)
|
hVWF/NGlyco:6
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G07799LX. Example: UniProtKB:P04275-1, Asn-156, MOD:00160~GNO:G07799LX." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053347 |
von Willebrand factor N-glycosylated 7 (human)
|
hVWF/NGlyco:7
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P04275-1, Asn-156, MOD:00160~GNO:G08293MJ." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053348 |
von Willebrand factor N-glycosylated 8 (human)
|
hVWF/NGlyco:8
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G15038BD. Example: UniProtKB:P04275-1, Asn-156, MOD:00160~GNO:G15038BD." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053349 |
von Willebrand factor N-glycosylated 9 (human)
|
hVWF/NGlyco:9
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G29279QO. Example: UniProtKB:P04275-1, Asn-156, MOD:00160~GNO:G29279QO." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053350 |
von Willebrand factor N-glycosylated 10 (human)
|
hVWF/NGlyco:10
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G41044JW. Example: UniProtKB:P04275-1, Asn-156, MOD:00160~GNO:G41044JW." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053351 |
von Willebrand factor N-glycosylated 11 (human)
|
hVWF/NGlyco:11
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G75568BH. Example: UniProtKB:P04275-1, Asn-156, MOD:00160~GNO:G75568BH." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053352 |
von Willebrand factor N-glycosylated 12 (human)
|
hVWF/NGlyco:12
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G83555HU. Example: UniProtKB:P04275-1, Asn-156, MOD:00160~GNO:G83555HU." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053353 |
von Willebrand factor N-glycosylated 13 (human)
|
hVWF/NGlyco:13
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G84664JR. Example: UniProtKB:P04275-1, Asn-156, MOD:00160~GNO:G84664JR." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053354 |
von Willebrand factor N-glycosylated 14 (human)
|
hVWF/NGlyco:14
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G85144OK. Example: UniProtKB:P04275-1, Asn-156, MOD:00160~GNO:G85144OK." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053355 |
von Willebrand factor N-glycosylated 15 (human)
|
hVWF/NGlyco:15
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G86752LQ. Example: UniProtKB:P04275-1, Asn-156, MOD:00160~GNO:G86752LQ." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053356 |
von Willebrand factor N-glycosylated 16 (human)
|
hVWF/NGlyco:16
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-156 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P04275-1, Asn-156, MOD:00160~GNO:G94917XT." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053357 |
von Willebrand factor N-glycosylated 17 (human)
|
hVWF/NGlyco:17
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-1574 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P04275-1, Asn-1574, MOD:00160~GNO:G08293MJ." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053358 |
von Willebrand factor N-glycosylated 18 (human)
|
hVWF/NGlyco:18
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-1574 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G41247ZX. Example: UniProtKB:P04275-1, Asn-1574, MOD:00160~GNO:G41247ZX." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053359 |
von Willebrand factor N-glycosylated 19 (human)
|
hVWF/NGlyco:19
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-1574 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:P04275-1, Asn-1574, MOD:00160~GNO:G58001LT." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053360 |
von Willebrand factor N-glycosylated 20 (human)
|
hVWF/NGlyco:20
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-211 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P04275-1, Asn-211, MOD:00160~GNO:G08293MJ." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053361 |
von Willebrand factor N-glycosylated 21 (human)
|
hVWF/NGlyco:21
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-211 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P04275-1, Asn-211, MOD:00160~GNO:G88374WZ." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053362 |
von Willebrand factor N-glycosylated 22 (human)
|
hVWF/NGlyco:22
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-2223 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P04275-1, Asn-2223, MOD:00160~GNO:G00912UN." [GlyGen:P04275-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053363 |
von Willebrand factor N-glycosylated 23 (human)
|
hVWF/NGlyco:23
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-2223 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P04275-1, Asn-2223, MOD:00160~GNO:G08293MJ." [GlyGen:P04275-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053364 |
von Willebrand factor N-glycosylated 24 (human)
|
hVWF/NGlyco:24
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-2223 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G83555HU. Example: UniProtKB:P04275-1, Asn-2223, MOD:00160~GNO:G83555HU." [GlyGen:P04275-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053365 |
von Willebrand factor N-glycosylated 25 (human)
|
hVWF/NGlyco:25
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-2223 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G86752LQ. Example: UniProtKB:P04275-1, Asn-2223, MOD:00160~GNO:G86752LQ." [GlyGen:P04275-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053366 |
von Willebrand factor N-glycosylated 26 (human)
|
hVWF/NGlyco:26
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-2223 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P04275-1, Asn-2223, MOD:00160~GNO:G94917XT." [GlyGen:P04275-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053367 |
von Willebrand factor N-glycosylated 27 (human)
|
hVWF/NGlyco:27
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-2546 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P04275-1, Asn-2546, MOD:00160~GNO:G08293MJ." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053368 |
von Willebrand factor N-glycosylated 28 (human)
|
hVWF/NGlyco:28
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-666 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P04275-1, Asn-666, MOD:00160~GNO:G08293MJ." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053369 |
von Willebrand factor N-glycosylated 29 (human)
|
hVWF/NGlyco:29
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-666 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G16175ZV. Example: UniProtKB:P04275-1, Asn-666, MOD:00160~GNO:G16175ZV." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053370 |
von Willebrand factor N-glycosylated 30 (human)
|
hVWF/NGlyco:30
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-666 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G27126ED. Example: UniProtKB:P04275-1, Asn-666, MOD:00160~GNO:G27126ED." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053372 |
von Willebrand factor N-glycosylated 32 (human)
|
hVWF/NGlyco:32
|
"A von Willebrand factor (human) that has been N-glycosylated at the residue equivalent to Asn-666 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P04275-1, Asn-666, MOD:00160~GNO:G88374WZ." [GlyGen:P04275-1, PMID:23345538, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053373 |
von Willebrand factor O-glycosylated 1 (human)
|
hVWF/OGlyco:1
|
"A von Willebrand factor (human) that has been O-glycosylated at the residue equivalent to Ser-1263 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P04275-1, Ser-1263, MOD:00002~GNO:G29068FM." [GlyGen:P04275-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053374 |
von Willebrand factor O-glycosylated 2 (human)
|
hVWF/OGlyco:2
|
"A von Willebrand factor (human) that has been O-glycosylated at the residue equivalent to Ser-1263 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P04275-1, Ser-1263, MOD:00002~GNO:G43417UB." [GlyGen:P04275-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053375 |
von Willebrand factor O-glycosylated 3 (human)
|
hVWF/OGlyco:3
|
"A von Willebrand factor (human) that has been O-glycosylated at the residue equivalent to Ser-746 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P04275-1, Ser-746, MOD:00002~GNO:G29068FM." [GlyGen:P04275-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053376 |
von Willebrand factor O-glycosylated 4 (human)
|
hVWF/OGlyco:4
|
"A von Willebrand factor (human) that has been O-glycosylated at the residue equivalent to Ser-746 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P04275-1, Ser-746, MOD:00002~GNO:G43417UB." [GlyGen:P04275-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053377 |
von Willebrand factor O-glycosylated 5 (human)
|
hVWF/OGlyco:5
|
"A von Willebrand factor (human) that has been O-glycosylated at the residue equivalent to Thr-1255 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P04275-1, Thr-1255, MOD:00005~GNO:G29068FM." [GlyGen:P04275-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053378 |
von Willebrand factor O-glycosylated 6 (human)
|
hVWF/OGlyco:6
|
"A von Willebrand factor (human) that has been O-glycosylated at the residue equivalent to Thr-1255 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P04275-1, Thr-1255, MOD:00005~GNO:G43417UB." [GlyGen:P04275-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053379 |
von Willebrand factor O-glycosylated 7 (human)
|
hVWF/OGlyco:7
|
"A von Willebrand factor (human) that has been O-glycosylated at the residue equivalent to Thr-1255 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P04275-1, Thr-1255, MOD:00005~GNO:G53434XO." [GlyGen:P04275-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053380 |
von Willebrand factor O-glycosylated 8 (human)
|
hVWF/OGlyco:8
|
"A von Willebrand factor (human) that has been O-glycosylated at the residue equivalent to Thr-1255 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G73004SD. Example: UniProtKB:P04275-1, Thr-1255, MOD:00005~GNO:G73004SD." [GlyGen:P04275-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053381 |
von Willebrand factor O-glycosylated 9 (human)
|
hVWF/OGlyco:9
|
"A von Willebrand factor (human) that has been O-glycosylated at the residue equivalent to Thr-1256 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P04275-1, Thr-1256, MOD:00005~GNO:G43417UB." [GlyGen:P04275-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053382 |
von Willebrand factor O-glycosylated 10 (human)
|
hVWF/OGlyco:10
|
"A von Willebrand factor (human) that has been O-glycosylated at the residue equivalent to Thr-1468 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P04275-1, Thr-1468, MOD:00005~GNO:G43417UB." [GlyGen:P04275-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053383 |
von Willebrand factor O-glycosylated 11 (human)
|
hVWF/OGlyco:11
|
"A von Willebrand factor (human) that has been O-glycosylated at the residue equivalent to Thr-1477 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P04275-1, Thr-1477, MOD:00005~GNO:G43417UB." [GlyGen:P04275-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053384 |
von Willebrand factor O-glycosylated 12 (human)
|
hVWF/OGlyco:12
|
"A von Willebrand factor (human) that has been O-glycosylated at the residue equivalent to Thr-2298 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P04275-1, Thr-2298, MOD:00005~GNO:G29068FM." [GlyGen:P04275-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000053385 |
von Willebrand factor O-glycosylated 13 (human)
|
hVWF/OGlyco:13
|
"A von Willebrand factor (human) that has been O-glycosylated at the residue equivalent to Thr-2298 of the amino acid sequence represented by UniProtKB:P04275-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P04275-1, Thr-2298, MOD:00005~GNO:G43417UB." [GlyGen:P04275-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000067037 |
von Willebrand factor methylated 1 (human)
|
hVWF/Me:1
|
"A von Willebrand factor (human) that has been methylated on the residue at the position equivalent to Cys-388 of the amino acid sequence represented by UniProtKB:P04275-1. Example: UniProtKB:P04275-1, Cys-388, MOD:00660." [IEDB_epitope:1007384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | |
organism-modification
|
|
PR:000073276 |
von Willebrand factor cysteinylated 1 (human)
|
hVWF/Cyst:1
|
"A von Willebrand factor (human) that has been cysteinylated on the residue at the position equivalent to Cys-914 of the amino acid sequence represented by UniProtKB:P04275-1. Example: UniProtKB:P04275-1, Cys-914, MOD:00765." [IEDB_epitope:152864, IEDB_epitope:152865, PRO:DNx]
|
|
|
|
|
